Navidea Biopharmaceuticals Inc (NYSE MKT LLC:NAVB)

1.70
BATS BZX Real-Time Price
As of 11:39am ET
 +0.02 / +1.19%
Today’s Change
0.97
Today|||52-Week Range
2.02
-10.05%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2014
Quarter 3
2014
Quarter 4
2014
Quarter 1
2015
Revenue and IncomeNet Revenues1.1M2.3M2.2M2.1M
 
 
 
 
 
Cost of Goods Sold146.4K682.5K175.1K299.2K
 
 
 
 
 
Depreciation And Amortization124.1K125.3K139.5K149.8K
 
 
 
 
 
 
Operating ExpensesGross Income804.2K1.4M1.9M1.7M
 
 
 
 
 
General Expenses8.6M6.7M6.4M8.1M
 
 
 
 
 
Research And Development5.1M4.2M2.3M4.0M
 
 
 
 
 
Total Operating Expenses8.9M7.5M6.7M8.5M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-7.8M-5.3M-4.5M-6.4M
 
 
 
 
 
Extraordinary Credit0.000.000.001.7M
 
 
Extraordinary Charge-1.5M-472.7K-1.2M-1.4M
 
 
 
 
 
Pre-Tax Equity Earnings---262.2K-261.6K-262.2K
 
 
 
 
Interest Expense On Debt914.1K920.9K927.4K966.6K
 
 
 
 
 
Other Expenses-5.3K53.5K31.3K26.5K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-10.2M-6.9M-6.9M-7.3M
 
 
 
 
 
Minority Interest0.000.000.00-100.00
 
 
Preferred Dividend0.000.000.00-46.0K
 
 
Net Income-10.2M-6.9M-6.9M-7.3M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS150.0M150.2M149.9M149.8M
 
 
 
 
 
Shares To Calculate EPS Diluted150.0M150.2M149.9M149.8M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.07-$0.05-$0.05-$0.05
 
 
 
 
 
EPS Diluted-$0.07-$0.05-$0.05-$0.05
 
 
 
 
 
 

To view my watchlist

Not a member yet?

Sign up now for a free account